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Abstract
Background: Regulatory T cells (Tregs) play an essential role in the control of the immune response. Treg cells
represent important targets for therapeutic interventions of the immune system. Therefore, it will be very
important to understand in more detail which genes are specifically activated in Treg cells versus T helper (Th)
cells, and which gene regulatory circuits may be involved in specifying and maintaining Treg cell homeostasis.
Results: We isolated Treg and Th cells from a genetically diverse family of 31 BXD type recombinant inbred strains
and the fully inbred parental strains of this family–C57BL/6J and DBA/2J. Subsequently genome-wide gene
expression studies were performed from the isolated Treg and Th cells. A comparative analysis of the
transcriptomes of these cell populations allowed us to identify many novel differentially expressed genes. Analysis
of cis- and trans-expression Quantitative Trait Loci (eQTLs) highlighted common and unique regulatory
mechanisms that are active in the two cell types. Trans-eQTL regions were found for the Treg functional genes
Nrp1, Stat3 and Ikzf4. Analyses of the respective QTL intervals suggested several candidate genes that may be
involved in regulating these genes in Treg cells. Similarly, possible candidate genes were found which may
regulate the expression of F2rl1, Ctla4, Klrb1f. In addition, we identified a focused group of candidate genes that
may be important for the maintenance of self-tolerance and the prevention of allergy.
Conclusions: Variation of expression across the strains allowed us to find many novel gene-interaction networks in
both T cell subsets. In addition, these two data sets enabled us to identify many differentially expressed genes and
to nominate candidate genes that may have important functions for the maintenance of self-tolerance and the
prevention of allergy.
Background
Regulatory T cells (Tregs) are key modulators of
immune responses in mice and humans and represent
key candidates for therapeutic interventions of a broad
variety of immunological diseases [1]. While reduction
or functional inactivation of Tregs would be beneficial
for restoration of anti-tumor immunity, selective
expansion of Tregs is a promising approach for prevent-
ing autoimmunity, allergy and organ graft rejection in
the transplantation setting. Initially being described as
thymus-derived CD25+ subpopulation within the naïve
CD4+ T-helper cell (Th) pool [2], during the last decade
extensive gene expression studies based on the compari-
son of CD25+CD4+ Tregs and CD25-CD4+ T helper
cells (Th) revealed a considerable number of additional
genes critically involved in Treg development and func-
tion [3-9]. Among those, the transcription factor FOXP3
was identified as master-regulator of the Treg lineage
[10-12].
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Defects in the Foxp3 gene function in humans and
mice result in fatal autoimmunity, and Foxp3 over-
expression in previously naïve T cells converts them to
Treg-like cells with in vivo and in vitro suppressive
function. Despite increasing knowledge regarding the
molecular signature of Tregs and mechanisms underly-
ing their suppressive function, the extent to which Treg
development and function are genetically controlled has
not been studied to date.
To better understand gene variants that underlie dis-
ease predispositions related to Treg functions and to
identify regulatory networks related to both Treg and
Th cells, we undertook a systems genetics analysis of
gene expression in these cell types using a genetic refer-
ence panel consisting of 31 members of the large BXD
family of recombinant inbred strains [13,14]. Genetic
reference panels (GRPs) such as the BXD family, are
sets of strains that have a defined and fixed genetic
architecture that can be used in classic linkage studies
and complex trait analysis. The BXD family is one of
the largest GRP, consisting of ~150 lines of which 80
are now fully inbred that all trace their descent from F2
progeny of crosses between C57BL/6J (B) and DBA/2J
(D). Individuals within a single BXD strain are nearly
isogenic (except for the sex chromosomes) and geno-
types for the entire family of strains are known and
stable [15]. The high level of genetic variation among
BXD strains can be exploited to systematically study the
genetic control of gene expression even at the level of
single cell types [16] and even higher order genotype-to-
phenotype relations, including for example global analy-
sis of disease susceptibility [17-19].
Recently, whole-genome transcriptome data have been
collected from GRPs. The expression level of a given
transcript in a cell type or tissue may be then treated as
a quantitative trait, and by employing standard linkage
analyses so-called expression quantitative trait loci
(eQTLs) can be identified. This links differences in
expression to specific chromosomal intervals [16,20-22].
eQTL analysis can be used to identify regulatory interac-
tions and to analyze specific effects of treatment or cell
type on transcriptional control [23-27]. In addition, the
analysis of eQTLs in chromosomal regions linked to dis-
ease susceptibility can help identify key candidate genes
[23,28,29].
Here, we report the whole transcriptome analysis of
steady-state Terg and Th cells that were isolated from
33 members of the BXD family, including the parental
strains. Variation of expression across the strains
allowed us to identify many novel gene-interaction net-
works in both T cell subsets. In addition, these two data
sets enable us to nominate candidate genes that may
have important functions for the maintenance of self-
tolerance and the prevention of allergy.
Results
CD4+CD25+ T regulatory (Treg) cells and CD4+CD25-
T helper (Th) cells were isolated from the spleens of 31
BXD strains and the parental strains DBA/2J and
C57BL/6J by fluorescence activated cell sorting. Subse-
quently, whole genome transcriptome analysis was per-
formed separately for each BXD strain and for Treg and
Th cells.
The gene expression data has subsequently been used
for two types of analysis. (1) A direct comparison of all
genes that were expressed in Treg versus Th detected
was performed from all samples together to identify dif-
ferentially expressed genes in either cell type. Here, the
variation in expression patterns between strains was not
taken into account. These studies allowed us to identify
a large number of novel, Treg-specific genes. (2) Differ-
ences in gene expression patterns between strains were
used to determine eQTLs in Treg and Th cells, sepa-
rately. This analysis allowed us to identify cis- and
trans-eQTLs, potential gene regulatory interactions and
candidate genes involved in autoimmune disease.
Analysis of differentially expressed genes reveals known
and novel gene candidates important for Treg and Th
functions
The large data set - for each cell type a total of 33 repli-
cates has been generated - provided a high statistical
power to identify genes that were differentially expressed
in Treg versus Th cells. We identified differentially
expressed genes by employing a statistical test on the
difference between the two T cell populations, setting
the threshold for the p-value to < 0.001 and using an
expression difference of at least two-fold. In the follow-
ing, probesets that exhibited a statistically significant
and at least two-fold difference in expression between
Treg and Th cells are referred to as ‘DE-2fold genes’. In
this way, a total of 14,117 probesets was found that
exhibited a significantly higher expression level in Treg
compared to Th cells (additional file 1, Table S1). 608
probesets were found from transcripts that were at least
two-fold higher expressed in Treg cells (DE-2fold
genes), including 413 annotated genes. On the other
hand, using the same criteria, for Th expressed genes, a
total of 11.944 probesets was found significantly higher
expressed in Th compared to Treg cells, and 823 probe-
sets, containing 481 annotated genes, showed a two-fold
or higher expression level (DE-2fold genes) in Th cells
(additional file 2, Table S2).
A total of 15 genes with known Treg functions (see
additional file 3, Table S3) were found amongst the dif-
ferentially expressed genes (additional file 3, Table S4),
including well known Treg functional genes like Foxp3
(forkhead box P3), Nrp1 (neuropilin 1), Itgae/aEb7
(integrin alpha E, epithelial-associated), Ctla4 (cytotoxic
Alberts et al. BMC Genomics 2011, 12:610
http://www.biomedcentral.com/1471-2164/12/610
Page 2 of 14
T-lymphocyte-associated protein 4), Ikzf4/Eos (IKAROS
family zinc finger 4). Il2ra/CD25 (interleukin 2 receptor,
alpha chain) was found to be highly expressed in Treg
compared to Th cells (25-fold higher) which is expected,
because the resting Treg subset was isolated on the basis
of CD25 surface expression. Also, Foxp3, representing
the most important Treg functional gene in mice, was
found to be expressed 43-fold higher in Treg cells. GO
term analyses for the DE genes revealed substantial dif-
ferences between Tregs and Th. Whereas lymphocyte
activation was indicated for Treg genes, antigen proces-
sing and presentation was strongly associated to Th
genes (data not shown).
These results confirmed successful separation of
highly pure Treg and Th subsets and corroborates the
value of our data for subsequent analyses. Furthermore,
the comparison of Treg and Th gene expression data
from a large sample size allowed us to identify a large
number of genes that are differentially expressed
between Treg and Th cells and may play a role in the
differentiation and maintenance or the function of the
respective cell populations.
Global analyses of eQTL mapping reveals different eQTLs
between Treg and Th cell populations
The analysis of gene expression patterns across 31 BXD
and the two parental strains allowed determining eQTLs
as quantitative traits by comparing expression values for
each gene and associating them with markers along the
genome in all strains.
In principle, two types of eQTLs can be distinguished.
If an eQTL is located at the same genomic position as
the gene itself (within an operationally defined 10 Mb
interval of the gene), it is considered as a cis-eQTL. In
this case, variations in the promoter sequence or in
regions that determine the stability of the mRNA of the
gene are the most likely causes for the observed differ-
ences. If the eQTL is at a distant location (operationally
defined as a distance exceeding 10 Mb) from the regu-
lated gene, it is referred to as a trans-eQTL. For exam-
ple, a transcription factor may be located in the eQTL
interval which regulates the expression of the target
gene. In this way, many gene regulatory regions but also
gene-gene interactions and networks may be identified.
Therefore, we performed a search for e-QTLs at a glo-
bal level for all probesets. Figures 1 and 2 show the
position of all cis- and trans-eQTLs in Treg and Th
cells, respectively. The analysis revealed that the overall
distribution of trans-eQTLs between the two cell popu-
lations is different suggesting different regulatory cir-
cuits in the two cell types (see additional file 4, Figure
S1 and S2 for direct comparisons of Treg and Th gen-
ome graphs).
Many cis eQTL loci are shared between Treg and Th cells
We then identified all cis- and trans-eQTLs in both
Treg and Th data sets with an LRS value of 18 or
higher. An LRS of 18 for trans-eQTLs corresponds to a
LOD score of 3.9 for trans-eQTLs and thus to a gen-
ome-wide p-value of about 0.05.
In the Treg data set, we identified 1,838 probesets
with cis-eQTLs with LRS scores of 18 or greater. In
comparison, we identified 2,153 probesets of this type in
the Th data set. Of these 1,346 probesets (~62.5%) were
common to both cell types.
Sixty-seven of the cis-eQTL probesets in Tregs also
represented DE-2fold genes for Tregs. Despite the large
overlap of cisQTL in the Th and Treg samples, 35 pro-
besets (52%) were only found in Treg samples and were
not detected as cis-eQTLs in Th using the above criteria
of a minimum LRS of 18 and DE-2fold for Treg (addi-
tional file 3, Table S5). However, it should be noted that
some probesets, e.g. Lad1 (ladinin) Naip5/Birc1e (NLR
family, apoptosis inhibitory protein 5) and Gbp4 (guany-
late binding protein 4)) also exhibited significant cis-
eQTLs in Th but the corresponding LRS did not reach
the threshold level of 18 (data not shown). Figure 3
shows Stx11 (syntaxin 11) as an example for a gene that
was expressed both in Treg and Th cells but exhibited a
strong cis-eQTL only in Treg cells. Stx11, Gsta4, Ctram,
Zfp467 exhibited a cis-eQTL in Treg and a trans-eQTL
in Th cells.
In the Th data set, 70 of the identified cis-eQTLs in
Th were also DE-2fold genes for Th cells. Of these, 35
probesets represented cis-eQTL genes that were only
found in Th cells and were not detected as cis-eQTLs
with a LRS of 18 or larger inTreg (additional file 3,
Table S6). However, some probestes also exhibited
strong cis-eQTLs in Treg but the corresponding LRS
did not reach the threshold level of 18, e.g. Snx5 (sorting
nexin 5, probeset 1417646_a_at) exhibited a significant
cis-eQTL in Th and a strong trans-eQTL in Treg cells
(data not shown). Similarly, Chn2, Cadm1 and Themis/
E430004N04Rik showed a cis-eQTL in Th and a trans
e-QTL in Treg cells.
Strong cis-eQTLs highlight genes that are differentially
expressed from the two parental alleles. They can be
employed in a forward genetic approach in subsequent
studies to elucidate the biological function of the respec-
tive genes.
Trans-eQTL mapping reveals different mechanisms of
gene regulation in Treg and Th cells
We then analyzed trans-eQTLs at a global level, using
again a LRS threshold of 18 or higher. 1,019 probesets
were identified which showed a trans-eQTLs in Treg
cells. Of these, 65 probesets exhibited trans-eQTLs that
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were present both in Treg and Th cells. 25 probesets
showed also a two-fold or higher level of expression
(DE-2fold genes) in Treg cells (additional file 3, Table
S7). Of these, all except BC010605 and Prdm5, repre-
sented Treg-specifc trans-eQTLs (see M&M for defini-
tion of Treg specific trans-eQTLs).
For Abcb1a (ATP-binding cassette, sub-family B
(MDR/TAP), member 1A), Gata1 (GATA binding pro-
tein 1), Mapkbp1 (mitogen-activated protein kinase
binding protein 1), Marco (macrophage receptor with
collagenous structure), and Nr4a2/Nurr1 (nuclear recep-
tor subfamily 4, group A, member 2) an immune-related
function, in some cases with regulating activity, has
been described (see discussion). Laptm4b (lysosomal-
associated protein transmembrane 4B) and Lycat (lyso-
cardiolipin acyltransferase 1) exhibited strong trans-
eQTL signals in both cell types but at different chromo-
somal locations (Figures 4 and S3, respectively).
In the Th data set, 1,099 probesets were identified
exhibiting a trans-eQTLs of 18 or higher. Of these, 30
probesets showed a two-fold or higher level of expres-
sion (DE-2fold genes) in Th cells (additional file 3,
Table S8) and all, except BC018101 and Prpf3, repre-
sented Th-specifc trans-eQTLs.
The expression of Prpf3 (PRP3 pre-mRNA processing
factor 3 homolog (yeast)) showed strong and shared
trans-eQTLs in Th and Treg cells (additional file 4, Fig-
ure S4), whereas St8sia1 (ST8 alpha-N-acetyl-neurami-
nide alpha-2,8-sialyltransferase 1), Crtam (cytotoxic and
regulatory T cell molecule), Igfbp4 (insulin-like growth
factor binding protein 4) and Sell (selectin, lymphocyte)
exhibited strong trans-eQTL signals in both cell types
but at different chromosomal locations (data not
shown).
In summary, the identification of cell-specific trans-
eQTL regions allowed the subsequent analyses of candi-
dates in the respective regions and to propose novel
gene-gene regulatory interactions (see below).
QTLs analysis for known functional Treg genes shows
trans-regulation for Nrp1 in Treg
In order to identify gene interaction networks for genes
that may play an important role for Treg function, we stu-
died known Treg functional genes (see additional file 3,
Figure 1 Genome-wide graph of cis- and trans-eQTLs in Treg cells. The positions of the eQTLs are plotted against the locations of the
corresponding transcript along the genome. Cis-regulated genes are located along the diagonal, all other dots represent trans-regulated genes.
The significance level of each QTL is indicated by the color. FDR = 0.3.
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Table S3) that were differentially expressed in Treg cells
and that showed a high expression signal in Tregs (expres-
sion signal > 8). This analysis revealed four genes with
eQTLs of an LRS equal or larger than 14 (additional file 3,
Table S9): Tnfrsf1b (tumor necrosis factor receptor super-
family, member 1b), Nrp1 (neuropilin 1), Stat3 (signal
transducer and activator of transcription 3) and Ikzf4
(IKAROS family zinc finger 4). Nrp1 (additional file 4, Fig-
ure S5) and Tnfrsf1b (data not shown) exhibited a gen-
ome-wide significant trans-eQTL, whereas the eQTLs for
Stat3 and Ikzf4 did not reach genome-wide significance
levels. Also, Foxp3 and Ctla4 did not exhibit any signifi-
cant cis- or trans-eQTLs in Treg cells.
These trans-eQTL regions were subsequently used to
propose novel gene-gene regulatory interactions (see
below).
Analysis of candidate genes in trans-eQTL intervals
reveals novel gene-gene regulatory interactions and
relation to classical phenotype traits
Next, we analyzed several trans-eQTLs that were identi-
fied in the above analyses for candidate genes that may
be involved in the regulation of target gene expression
(additional file 3, Table S10). Below, we present the ana-
lysis of one QTL interval as an example. The results for
other QTL intervals can be found in additional file 5,
‘Additional Results and Discussion.
The interval on chromosome 4 (28 - 35 Mb) was
found to regulate expression of the F2rl1 gene (addi-
tional file 4, Figure S6). This region contains 37 probe-
sets which were well expressed (> 8) in Treg cells
(Table S11). Of these, Ccdc111 (coiled-coil domain con-
taining 111), Zfp292 (zinc finger protein 292),
1810030N24Rik, AI448984 and Map3k7 (mitogen-acti-
vated protein kinase kinase kinase 7) exhibited strong
cis-eQTLs (LRS > = 15) and thus are most likely candi-
dates for regulating the expression of F2rl1 in Treg cells.
Furthermore, we analyzed the same eQTL intervals for
the presence of a significant QTL in classical phenotypes
that are contained in the GeneNetwork database. A total
of 18 phenotypes could be found with an LRS of 18 or
larger. Of these, eight were related to immune and
infectious diseases traits (Table 1). Thus, the candidate
genes may also be involved in regulating these traits. It
Figure 2 Genome-wide graph of cis- and trans-eQTLs in Th cells. The positions of the eQTLs are plotted against the locations of the
corresponding transcript along the genome. Cis-regulated genes are located at the diagonal, all other dots represent trans-regulated genes. The
significance level of each QTL is indicated by the color. FDR = 0.3.
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should, however, be noted that our search algorithm
only detects classical phenotypes that exhibit a peak
QTL at this position. A more detailed analysis can be
performed manually for any phenotype of interest.
Analysis of autoimmune traits
In a previous study for autoimmune disease traits, two
QTLs were identifies that are associated with autoim-
mune traits in the BXD population. One QTL on chro-
mosome 2 was associated with elevated serum titers of
anti-DNA antibodies and a second locus on chromo-
some 4 with increased serum titers of rheumatoid factor
(RF) levels [30]. Therefore, we investigated these inter-
vals in our Treg and Th data sets.
The QTL interval (150 - 170 Mb) on chromosome 2
contains 286 probesets that were expressed in Treg cells
(signal > 8) and 290 probesets were expressed in Th
cells (signal > 8), respectively. We then identified the
genes that exhibit a cis-eQTL in Treg cells because
these may be involved in the regulation of autoimmunity
to DNA. 19 probesets were identified that also exhibited
a strong cis-eQTLs (LRS > = 15) in Treg cells (addi-
tional file 3, Table S12). The peak interval (160 - 165
Mb) contained the genes Ada (adenosine deaminase),
Slpi (secretory leukocyte peptidase inhibitor), Sys1/
2610042O14Rik (SYS1 Golgi-localized integral mem-
brane protein homolog (S. cerevisiae)), and Znf335 (zinc
finger protein 335). The cis-eQTL signal for Ada is
Figure 3 Genome wide eQTL mapping of Stx11 transcript in Treg and Th cells. (A) eQTL map for Stx11 (probeset 1453228_at) in Tregs and
(B) in Th, respectively. The numbers at the top are chromosomes, and positions at the bottom are given in megabases along the chromosome.
The blue line represents the significance level of the QTL expressed as LRS score (likelihood ratio statistic). A positive additive coefficient (green
line) indicates that DBA/2J alleles increased trait values. A negative additive coefficient (red line) indicates that C57BL/6J alleles increased trait
values. The two horizontal lines mark the genome-wide significance levels at p < 0.05 (red line) and p < 0.37 (gray line). A blue triangle marks
the position of the gene.
Alberts et al. BMC Genomics 2011, 12:610
http://www.biomedcentral.com/1471-2164/12/610
Page 6 of 14
Figure 4 Genome wide eQTL mapping of Laptm4b transcript in Treg and Th cells. (A) eQTL map for Laptm4b (probeset 1416148_at in
Tregs and (B) in Th, respectively. See figure 3 for explanation of labels.
Table 1 QTLs from classical phenotypes overlapping with eQTLs
Chromosome Mb Record Phenotype Max
LRS
Max LRS
Location (Chr:
Mb)
3 20-
30
12958 Blood chemistry, cardiovascular system: White blood cell count of 14-week old males 19 Chr3: 28.293133
4 28-
35
10410 Immune function: Antigenic activity of irradiated BXD spleen cells for Thy1+CD3+CD4+CD8-
T-cell clone TGVH32
31 Chr4: 31.651725
17 25-
45
11025 Infectious disease, immune function: Chlamydia psittaci (6BC) infection response (10^4 IFU
ip), pathogen load in peritoneal cavity at 30 days among surviving 3-5 month males
33.6 Chr17: 31.769795
17 25-
45
10466 Immune function, gastrointestinal system: Intestinal intraepithelial gamma-delta type T
lymphocytes (i-IELs) in 2-6 month old adults based on receptor expression (V-gamma-7
positive, Vgamma-4 negative T cells)
33.1 Chr17: 32.068297
17 25-
45
10236 Proliferation of JTL-G12 cells (T cell clone) with 50 ug/ml GAT (Glu60, Ala30, Tyr10) 24.5 Chr17: 32.068297
17 25-
45
10238 Proliferation of JTL-G12.8 (Tcell clone) with 50 ug/ml GAT (Glu60, Ala30, Tyr10) 26.7 Chr17: 32.068297
17 25-
45
10441 Anti-F antigen (liver protein) titer, experiment 1 19.1 Chr17: 26.950946
17 25-
45
12672 Infectious disease, immune function: Ectromelia virus survival over two weeks after a 90 pfu
intranasal inoculation, males and females between 40 and 150 days of age, residuals
corrected for sex, age, and body weight
19.5 Chr17: 31.179359
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most likely caused by SNPs in the hybridization probe.
Thus these genes, with the exception of Ada, represent
likely candidates for regulating this trait in Treg cells.
The results for the analysis of the chromosome 4 inter-
val can be found in the supplement data.
Discussion
Here, we studied the expression patterns of genes in
Treg and Th cells from a large number of individuals
from the BXD recombinant inbred strain collection. The
ultimate goal of these studies was the identification of
expression quantitative traits (eQTLs) and of co-regu-
lated genes that will give new insights into gene-gene
interactions and regulatory pathways. In addition, the
large data set of expression profiles from 33 mouse lines
allowed us to validate known and to newly identify so
far unknown genes that are expressed specifically in
Treg but not Th cells.
Until now, several studies have aimed to identify genes
that are specific for Treg cells (additional file 3, Table
S3). Using our data set from 33 mouse stains allowed us
to search for differences in expression levels in Treg
versus Th cells with a so far unprecedented statistical
power. Our analysis confirmed that many genes with a
described Treg function are also differentially expressed.
Of the 23 genes that were described in the literature as
genes with an important function in Treg cells, 17 were
also found to be Treg specific in our analysis. Of the
remaining six genes, Galectin-10 does not have a homo-
logue in humans. S1pr1a and Lrrc32 were not repre-
sented on the array. Also a Treg function for LRRC32/
GARP was so far only described in humans. The
remaining three genes, Gzmb, Lag3 and Il12rb2, were
expressed at low levels in both Treg and Th but with no
significant difference between the two cell types.
The genes Foxp3, Nrp1, Clta4, Tnfrsf18 /Gitr, Il2ra
/Cd25, Itgae /CD103, Ikzf4 /Eos, Gpr83 have been
reported to be hallmark genes for Treg cells [31,32].
Indeed, all of them appear as DE-2fold genes specifically
higher expressed in Treg cells. Since we discovered
Nrp1 as surface marker of murine regulatory T cells [3]
comprehensive data have been obtained regarding its
implications in Treg function [33-37]. Whereas expres-
sion of other Treg-markers such as Cd25 and Ctla4 are
induced upon activation of Th cells, activated murine
Th cells lack Nrp1 expression, suggesting fundamental
differences in the transcriptional regulation of this mole-
cule in Tregs when compared with other well described
Treg markers.
In total, 608 probesets were found in our analysis as
Treg-specific and with an expression difference of at
least two-fold. Although a difference of two-fold in
expression levels is often used in gene expression array
studies in many studies, it may be considered as
arbitrary. Our study allowed to find even more genes
with statistical significant differences in expression levels
and extended the known list to 14,117 probesets that
are specific for differentiated Treg versus Th cells.
Zheng et al. [38] performed chromatin immunoprecipi-
tation and genome tiling array profiling to identify direct
targets of the Foxp3 transcription factor. About 270
genes were identified were also up-regulated in Foxp3+
T cells. Of these, 162 genes were also found as differen-
tially expressed genes in our analysis.
Recently, a genome wide association study in a large
cohort of patients suffering from alopecia areata, which
is among the most highly prevalent human autoimmune
diseases, leading to disfiguring hair loss due to the col-
lapse of immune privilege of the hair follicle and subse-
quent autoimmune attack revealed an association with
genomic regions containing several genes controlling
the activation and proliferation of Tregs including
Ctla4, CD25, and Eos/Ikzf4 [39].
In conclusion, almost all genes described previously as
Treg functional genes or in other screening assays were
also found in our analysis. These findings confirm that
our study is well suitable to identify genes that are
important for Treg function, differentiation and/or
maintenance of their differentiation status.
Cis-eQTL genes most likely carry a mutation in the
promoter region or contain a structural variation in the
transcribed region which results in low expression levels
or unstable RNA of one but not the other allele. In our
study, several cis-eQTL genes were found that were
active both in Treg and Th cells and have a known
function in the immune response. For example, Stx11
(syntaxin 11) has been associated with familial hemo-
phagocytic lymphohistiocytosis 4 in humans [40,41].
BXD strains that carry a very low expressing allele
inherited from one of the parental strains are similar to
genetic knock-down experiments or hypomorphic
mutants [42]. The function of such genes can be studied
in a reverse genetics approach by comparing the mean
phenotypes of BXD strains that have inherited either the
low or high allele–a method referred to as reverse com-
plex trait analysis. Prominent examples of genes that are
nature “knock-downs” in the BXD strains, include Hc,
Ahr, Gpnmb, Tyrp1, Sae1, Apoa2, and several CLEC and
KLRA gene family members [23,42].
341 probesets represented cis-eQTLs shared by several
tissues, in Treg and Th cells but also in brain, kidney
and lung.
In Treg cells, 25 probeset were trans-regulated and
represented genes that were differently expressed
between Treg and Th cells and that showed a two-fold
or higher level of expression (DE-2fold genes) in Treg
cells. Several of them represented genes with a known
immune-related function. For example, Abcb1a (ATP-
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binding cassette, sub-family B (MDR/TAP), member 1A)
is involved in the down-modulation of dendritic cell
functions through the regulation of pro-inflammatory
cytokine secretion [43]. Gata1 (GATA binding protein
1) has been shown to be an important regulator of mast
cell differentiation [44]. Mapkbp1 (mitogen-activated
protein kinase binding protein 1) encodes a protein that
enhances NF-kappaB activation induced by MAP kinase
kinase kinase 7 and TNF Receptor-Associated Factor 2
[45]. Marco (macrophage receptor with collagenous
structure) exhibits multiple functions in the innate
immune response. MARCO, TLR2, and CD14 are
required for macrophage cytokine responses to myco-
bacterial trehalose dimycolate and Mycobacterium
tuberculosis [46]. MARCO-deficient mice exhibit lower
IL-12 production in responses to stimulation [47]. A
defect in Marco results in an impaired clearance of
apoptotic cells and a generalized defect in both endocy-
tosis and phagocytosis [48]. Expression of MARCO is
required for TLR signaling [46]. But Marco also exhibits
suppressive functions by decreasing inflammation in
lungs after exposure to ozone [49]. Nr4a2/Nurr1
(nuclear receptor subfamily 4, group A, member 2)
represents a transcriptional mediator of inflammatory
signals [50,51]. Also, it plays an important role in modu-
lating IL-8 expression [52].
Two genes, Laptm4b and Lycat exhibited strong trans-
eQTL signals in both cell types but at different chromo-
somal locations. Thus, the same genes are expressed in
both cell types, but are likely regulated by different
mechanisms. Laptm4b (lysosomal-associated protein
transmembrane 4B) is involved in cell proliferation and
multidrug resistance [53], whereas no biological function
has yet been described for Lycat (lysocardiolipin acyl-
transferase 1).
None of these genes represents a known Treg key
gene. Our analysis thus allows expanding the list of
genes with potentially important functions in Treg cells.
We did not perform an extensive analysis for trans-
eQTLs in Th cells but a similar result can be expected
for Th cells.
We then analyzed several trans-eQTLs for potential
regulator genes in order to propose possible novel gene-
regulatory circuits in Treg and Th cells. These are by
far not comprehensive but rather serve as examples to
illustrate how our data set will allow searching for possi-
ble regulatory networks.
A QTL region was found on chromosome 4 that regu-
lates the expression of the F2rl1 (coagulation factor II
(thrombin) receptor-like 1) gene. F2rl1/Par2 gene
expression has been associated with the activation and
suppression of inflammatory responses. Overexpression
of F2rl1 in allergic inflammation of the airway
exacerbates eosinophil infiltration into the lumen and
hyperreactivity of the airway, while F2rl1 deletion
diminishes inflammatory cell infiltration and reduces
hyperreactivity [54]. Also, F2rl1 plays a protective role
during influenza virus type A infection through IFN-
gamma production and decreased excessive recruitment
of inflammatory cells to lung alveoli [55] and deletion of
F2rl1 is associated with decreased clearance of P. aerugi-
nosa [56]. Several candidate genes in the chromosome 4
QTL interval, which regulates F2rl1 expression, exhib-
ited a cis-eQTL and thus represent potential regulators
of F2rl1 (Table S11). These include the Map3k7/Tak1
(mitogen-activated protein kinase kinase kinase 7) pro-
tein kinase gene which exhibits many immune modula-
tor functions. It mediates activation of IKK (inhibitor of
kappaB kinase) and silencing of Map3k7 suppressed T
cell receptor-dependent IKK activation and interleukin-2
production in T cells [57,58]. The Zfp292 (zinc finger
protein 292) gene expression has been shown tocorrelate
with growth hormone expression and may thus be
involved in mediating proliferation signals [59]. The
analysis of candidate genes in the other QTL regions is
discussed in the supplement data.
Our analysis of the chromosome 2 regions autoim-
mune trait [30] identified several loci that exhibited a
cis-eQTL in Treg cells and may thus be involved in reg-
ulating this trait: Slpi, Sys1/2610042O14Rik, and Znf335.
Slpi (secretory leukocyte peptidase inhibitor) exhibits
many biological functions, including anti-bacterial, anti-
fungal, anti-viral, anti-inflammatory, wound healing and
immuno-modulatory activities [60-68]. The Slpi protein
represents a ligand for PLSCR1 and PLSCR4, which
interact directly with the CD4 receptor at the cell sur-
face of T lymphocytes [69]. Slpi is a prominent innate
immune protein of the respiratory tract with serine pro-
tease inhibitor activity [70]. It attenuates excessive
inflammatory responses resulting in a balanced innate
immunity [71,72]. Constitutive expression of Slpi
reduced the inflammatory response and improved lung
function in an acute model of allergic asthma in Slpi
transgenic and knockout mice [73]. The attenuation of
the inflammatory response by Slpi is mediated through
macrophages that secrete an increased amount of Slpi
when encountering apoptotic cells [74,75]. Znf335 (zinc
finger protein 335, also NIF1 in human) is a cotransdu-
cer that regulates the activity of the nuclear hormone
receptor coactivator NRC [76] which may mediate the
function of the CCR4 signal [77]. No biological func-
tions were identified so far for Sys1 (SYS1 Golgi-loca-
lized integral membrane protein homolog (S.
cerevisiae)). The discussion of candidate genes in the
chromosome 4 auto-immune QTL interval can be found
in the supplemental data.
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Conclusions
Our study revealed many novel Treg specific genes and
also points to genes that may regulate important gene-
gene interactions in Treg cells. These interactions, once
validated, should allow proposing new targets for thera-
peutic interventions in cancer, auto-immunity, and
allergies.
Methods
Mouse strains and sample preparation
Parental and BXD lines were received from Jackson
Laboratory, or from The Oak Ridge National Laboratory
(BXD43, BXD51, BXD61, BXD62, BXD65, BXD68,
BXD69, BXD73, BXD75, BXD87, BXD90), and were bred
in the facility of the Neuro-BSIK consortium (VU Univer-
sity Amsterdam). Mice were housed on sawdust in stan-
dard Makrolon type II cages with food (Harlan Teklad
2018) and water ad libitum under specific pathogen free
conditions. For the analysis, mice were transferred to the
animal facility in Braunschweig and adapted for at least
two weeks to the new environment before preparing the
spleen cells. All protocols involving mice were approved
by national animal welfare committees.
Sorting of Tregs and Th cells by fluorescent activated cell
sorting
For sorting of Tregs and Th cells, splenocytes from 31
BXD recombinant inbred strains as well as from the
parental mouse lines DBA/2J and C57BL/6J were iso-
lated by flushing the spleens with erythrocyte-lysis-buf-
fer. Cells were collected by centrifugation, re-suspended
in cold FACS-buffer (PBS/2% FCS/0.5 mM EDTA). For
each strain and sex, the cells from three individual mice
were pooled. After passing the cells through a 100 μm
cell strainer and an additional washing step with FACS-
buffer, splenocytes were stained with anti-CD4-APC and
anti-CD25-PE (BD Biosciences (Heidelberg, Germany))
for 10 minutes at 4°C, washed and re-suspended in
FACS-buffer. CD4+ T cells were separated into CD4
+CD25+ Treg and CD4+CD25- Th cells using a MoFlo
cell sorter (Cytomation) and purity of the sorted T cell
subsets reached 95-97%.
Microarray analysis
Quality and integrity of the total RNA isolated from 1 ×
105 cells was controlled by running all samples on an
Agilent Technologies 2100 Bioanalyzer (Agilent Tech-
nologies; Waldbronn, Germany). RNA amplification and
labelling was done according to manufactures protocol
(Small Sample Target Labeling Assay Version II, Affy-
metrix; Santa Clara, CA). The concentration of biotin-
labeled cRNA was determined by UV absorbance. In all
cases, 10 μg of each biotinylated cRNA preparation were
fragmented and placed in a hybridization cocktail con-
taining four biotinylated hybridization controls (BioB,
BioC, BioD, and Cre) as recommended by the manufac-
turer. Samples were hybridized to an identical lot of
Affymetrix MOE430 2.0 for 16 hours at 46°C. After
hybridisation the GeneChips were washed and stained
using the Affymetrix’s recommended EukGE-WS2v5
protocol for GeneChip® Fluidics FS400 station. Images
were scanned using GeneChip® Scanner 3000 under the
control of GCOS 1.3 software package (Affymetrix;
Santa Clara, CA)
Data preprocessing and analysis
Microarray data was preprocessed using the RMA
method [78] and log2 values were computed. The Z
scores for each cell value was then calculated (including
subtraction of means and division by standard devia-
tions), multiplied by 2 and a value of 8 was added. The
advantage of this variant of a Z transformation is that all
values are positive and that 1 unit represents approxi-
mately a 2-fold difference in expression as determined
using the spike-in control probesets (see [26] for details).
The data was then batch corrected [79]. In this study,
RNA was extracted at three different points in time for
the Treg samples and also microarray processing was
performed at three different points in time. Similarly, the
Th samples were processed in two batches. Therefore, we
performed a batch correction for both cell types using
the following ANOVA model before further analysis of
the data: yi = μ + Bi + ei where yi is the expression level
of the ith microarray, μ is the overall mean, Bi is the
batch to which the ith individual belongs and ei is the
residual error. Finally, mean values were calculated if
multiple samples from one BXD line were recorded
(male and females or replicates) and the processed data
were stored and are publically available in the GeneNet-
work (GN) database [20]. Identification and QTL ana-
lyses were performed using the GeneNetwork web
service [20] as previously described [23].
Differentially expressed probes between Treg and Th
were calculated by applying the moderated F-statistic
[80], an empirical Bayes method, Cut-offs were set to
pFDR < = 0.001 and fold change > = 2×. Probes signifi-
cantly higher expressed either in Treg or Th, respec-
tively, were tested for statistically associated GO terms
via the hypergeometric test. Data analyses were done in
the R environment with Bioconductor [81] and packages
limma [78] and GOstats [82].
The GeneRIF database http://www.ncbi.nlm.nih.gov/
projects/GeneRIF/GeneRIFhelp.html was used as a pri-
mary source to search for known gene functions and to
cite these in the discussion. We also tested whether a
trans-eQTLs obtained in one data set is specific for this
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cell type. GeneNetwork does not have an automatic
function for such an analysis. We therefore tested this
feature manually in the following way. For trans-eQTLs
with an LRS of 18 or higher in Treg cells, the LRS was
determined at the same marker positions in the Th data
set. If the LRS in Th was less that 6 (which corresponds
to a p-value of less than 0.05 at this marker - not a gen-
ome-wide significance) the QTL in Treg was considered
“Treg-specific”. The analysis was performed likewise to
determine Th-specifc trans-eQTLs.
Access to microarray data
The processed data and analysis tools are available at
the GeneNetwork database http://www.genenetwork.
org/webqtl/main.py, accession number for Treg data:
GN122; accession number for Th data: GN319. The raw
and processed data are accessible from the ArrayExpress
database, ID: E-MTAB-836.
Additional material
Additional file 1: Table S1. Treg specific genes. The table lists genes
that exhibited a differential expression in Treg compared to Th cells.
Probeset: probeset ID of microarray hybridization probe, logFC: fold
changes of expression level in Treg versus Th as difference of log2 values,
pFDR: FDR-corrected p-value, Treg: expression level in Treg cells as log2
value, Th: expression level in Th cells as log2 value.
Additional file 2: Table S2 Th specific genes. The table lists genes that
exhibited a differential expression in Th compared to Treg cells. Probeset:
probeset ID of microarray hybridization probe, logFC: fold changes of
expression level in Treg versus Th as difference of log2 values (a negative
value represents higher expression in Th compared to Treg cells), pFDR:
FDR-corrected p-value, tr: expression level in Treg cells as log2 value, th:
expression level in Th cells as log2 value.
Additional file 3: Table S3 Genes with known functions in Treg cells.
The table lists genes that have been described in the literature to exhibit
a functional role in Treg cells. Table S4: Treg functional genes with a
higher expression in Tregs. The table lists probesets of genes that
were expressed at a higher level in Treg compared to Th cells and which
exhibit known Treg functions. Table S5. Genes regulated by cis-eQTL
in Treg cells. The table lists probesets from genes that exhibited a cis-
eQTL larger or equal to an LRS of 18 in Treg but not in Th cells and
which were expressed at least 2-fold higher in Treg cells. Table S6.
Genes regulated by cis-eQTL (LRS > = 18) in Th. The table lists
probesets from genes that exhibited a cis-eQTL larger or equal to an LRS
of 18 in Th but not in Treg cells and which were expressed at least 2-
fold higher in Th cells. Table S7. Treg specific genes regulated by
trans-eQTL in Treg cells. The table lists probesets from genes that
exhibited a trans-eQTL larger or equal to an LRS of 18 in Treg but not in
Th cells and which were expressed at least 2-fold higher in Treg cells.
Table S8. Th specific genes regulated by trans-eQTL in Th cells. The
table lists probesets from genes that exhibited a trans-eQTL larger or
equal to an LRS of 18 in Th but not in Treg cells and which were
expressed at least 2-fold higher in Th cells. Table S9. Treg functional
genes regulated and highly expressed in Treg cells. The table lists
probesets of differentially expressed genes in Treg cells with a known
Treg function, a high expression signal in Tregs (expression signal > 8)
and which are regulated by a trans-eQTL with an LRS > = 14. Table S10:
Intervals selected for further QTL analysis. The table lists the QTL
intervals from selected Treg and Th cis- and trans-eQTLs that were
further analyzed for the presence of candidate regulatory genes. Table
S11 Candidate genes located in the F2rl1-QTL interval on
chromosome 4. The table lists probesets of possible candidate genes
that are located in the QTL interval on chromosome 4 which regulates
the expression of F2rl1. Only genes with an expression signal larger than
8 were selected. Table S12 Candidate genes located in the QTL
interval on chromosome 2 (autoimmunity to DNA). The table lists
probesets of possible candidate genes that are located in the QTL
interval on chromosome 2 which regulates autoimmunity to DNA. Only
genes expressed in Treg cells (signal > 8 on log2 scale) and exhibiting a
cis-eQTL of LRS > = 15 were selected.
Additional file 4: Figure S1. Genome-wide graph of cis- and trans-
eQTLs in Treg and Th cells. The file shows the genome-wide mapping
graphs for Treg cells and the same graph for Th cells overlaid in grey.
Figure S2. Genome-wide graph of cis- and trans-eQTLs in Th and
Treg cells. The file shows the genome-wide mapping graphs for Th cells
and the same graph for Treg cells overlaid in grey. Figure S3, Genome
wide eQTL mapping of Lycat transcript in Treg and Th cells. The file
contains a graph showing the result of a genome-wide mapping of
eQTLs for the Lycat transcript in Treg and Th cells. Figure S4, Genome
wide eQTL mapping of Prpf3 transcript in Treg and Th cells. The file
contains a graph showing the result of a genome-wide mapping of
eQTLs for the Prpf3 transcript in Treg and Th cells. Figure S5, Genome
wide eQTL mapping of Nrp1 transcript in Treg and Th cells. The file
contains a graph showing the result of a genome-wide mapping of
eQTLs for the Nrp1 transcript in Treg and Th cells. Figure S6, Genome
wide eQTL mapping of F2rl1 transcript in Treg and Th cells. The file
contains a graph showing the result of a genome-wide mapping of
eQTLs for the F2rl1 transcript in Treg and Th cells. Figure S7, Genome
wide eQTL mapping of Ctla4 transcript in Treg and Th cells. The file
contains a graph showing the result of a genome-wide mapping of
eQTLs for the Ctla4 transcript in Treg and Th cells.
Additional file 5: ’Additional Results and Discussion’: This file
contains additional results on: Trans-eQTLs mapping in Treg and Th
cells, the analysis of candidate genes in trans-eQTL intervals, and
the analysis of autoimmune traits. Also, the file contains additional
discussion points on Treg-specifc genes, the analysis of the interval on
chromosome 2 found to regulate expression of Nrp1, analysis of an
interval on chromosome × regulating expression of Klrb1f/A630024B12Rik
(killer cell lectin-like receptor subfamily B member 1F) and Ctla4
(cytotoxic T-lymphocyte-associated protein 4), the analysis of known Treg
functional genes for possible cis- or trans-eQTLs, and the analysis of the
QTLs interval chromosome 4 associated with autoimmune traits.
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